Professor Montagnier made the remarks during a conference on the future of biomedical research at the European Parliament on April 7.
In answering a question on the expiration of the therapeutic vaccine, the scientist estimated that the vaccine could be completed “in four or five years from the time we start, when we are funded. It is a business of ten million. euros “. The project would be well defined, and would have an advantage over the preventive vaccine: “we can already demonstrate its effectiveness on a small number of patients”.
“In my opinion a lot of money has been wasted, not so much at European level but at global level, in the search for a preventive vaccine based on concepts which were false”, also affirmed Luc Montagnier.
He said he himself suffered that his therapeutic vaccine project had previously been refused at European level. To find a vaccine track, one possibility would, according to him, be to “identify the fraction of the virus which is resistant to triple therapy”, the “reservoir of the virus”.
